Tumor promoter 12-O-tetradecanoylphorbol-13-acetate-induced insulin secretion: Inhibition by phospholipase A2- and lipoxygenase-inhibitors
- 1 March 1982
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 105 (2), 759-765
- https://doi.org/10.1016/0006-291x(82)91499-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Phorbol esters parallel effects on tumor promotion, insulin release and calcium ionophoresisCancer Letters, 1981
- In Vitro Studies on the Mode of Action of the Phorbol Esters, Potent Tumor Promoters, Part 2CRC Critical Reviews in Toxicology, 1981
- Arachidonic acid and prostaglandin E2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell lineCancer Letters, 1981
- In vitro studies on the mode of action of the phorbol esters, potent tumor promoters: Part 1CRC Critical Reviews in Toxicology, 1980
- Phorbol Myristate Acetate: Effect of a Tumor Promoter on Insulin Release from Isolated Rat Islets of Langerhans*Endocrinology, 1978
- Effects of phorbol-12,13-diesters on prostaglandin production and phospholipase activity in canine kidney (MDCK) cellsBiochemical and Biophysical Research Communications, 1977
- The importance of phospholipase-A2 in prostaglandin biosynthesisBiochemical Pharmacology, 1976
- Phospholipase A2 and its zymogen from porcine pancreas. VI. Histidine at the active site of phospholipase A2Biochemistry, 1974
- Selective inhibition by mepacrine of the release of “rabbit aorta contracting substance” evoked by the administration of bradykininJournal of Pharmacy and Pharmacology, 1972
- Method for the Isolation of Intact Islets of Langerhans from the Rat PancreasDiabetes, 1967